Marie‐Bernadette Assié

Author

Pierre Fabre (France)

Also Known As

Marie-Bernadette Assié, Marie‐Bernadette Assie, Marie‐Bernadette Assié

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Pierre Fabre (France)Pierre Fabre (Germany)

About

Marie‐Bernadette Assié is an author at Pierre Fabre (France) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	609
2	Neuroscience	10	11	447
3	Social Sciences	9	9	421
4	Biochemistry	1	1	39
5	Neurology	1	1	32

Marie‐Bernadette Assié

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia Adrian Newman‐Tancredi, Marie‐Bernadette Assié, Nathalie Leduc, The International Journal of Neuropsychopharmacology	2005	132
Contrasting Contribution of 5-Hydroxytryptamine 1A Receptor Activation to Neurochemical Profile of Novel Antipsychotics: Frontocortical Dopamine and Hippocampal Serotonin Release in Rat Brain Marie‐Bernadette Assié, Véronique Ravailhe, Valérie Faucillon, Journal of Pharmacology and Experimental Therapeutics	2005	127
Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT<sub>1A</sub> Receptors Bernard Vacher, Bernard Bonnaud, Philippe Funes, Journal of Medicinal Chemistry	1999	107
F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity Marie‐Bernadette Assié, Laurent Bardin, Agnès L. Auclair, The International Journal of Neuropsychopharmacology In-vivo ProfileNeurotransmitterPsychopharmacologyExperimental PharmacologySocial Sciences	2010	106
Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties Marie‐Bernadette Assié, Wouter Koek European Journal of Pharmacology Molecular PharmacologyHippocampal 5-Hydroxytryptamine LevelsMedicinePhysiology5-Ht1a Receptor Antagonists	1996	82
Pharmacological Characterization of In Vivo Properties of Putative Mixed 5-HT1AAgonist/5-HT2A/2C Antagonist Anxiolytics. II. Drug Discrimination and Behavioral Observation Studies in Rats Mark S. Kleven, Marie‐Bernadette Assié, Wouter Koek Journal of Pharmacology and Experimental Therapeutics	1997	74
5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential Wouter Koek, Bernard Vacher, Cristina Cosi, European Journal of Pharmacology Molecular PharmacologyPsychiatryMood SymptomMedicinePsychotropic Medication	2001	63
The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: Comparison with aripiprazole, ziprasidone, bifeprunox and F15063 Marie‐Bernadette Assié, Elisabeth Carilla-Durand, Laurent Bardin, European Journal of Pharmacology Psychoactive DrugPsychiatryMedicineOlanzapine Increase PlasmaPsychotropic Medication	2008	54
5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine Marie‐Bernadette Assié, Cristina Cosi, Wouter Koek European Journal of Pharmacology Molecular PharmacologyPsychiatryFunctional SelectivityMedicinePsychotropic Medication	1997	53
In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat Laia Lladó-Pelfort, Marie‐Bernadette Assié, Adrian Newman‐Tancredi, Psychopharmacology NeurophysiologyMedicineFunctional SelectivityPhysiologyNeurotransmitter	2011	49

Page 1